CannLabs, Inc.
CANL · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.34 | -2.07 | -0.51 | -0.03 |
| FCF Yield | 11.88% | 1.99% | 2.37% | 17.64% |
| EV / EBITDA | 6.65 | 36.39 | 44.44 | 3.41 |
| Quality | ||||
| ROIC | 27.67% | 24.27% | 19.56% | 39.00% |
| Gross Margin | 46.97% | 53.39% | 45.05% | 57.90% |
| Cash Conversion Ratio | 0.89 | 0.75 | 1.10 | 0.69 |
| Growth | ||||
| Revenue 3-Year CAGR | 16.67% | 8.38% | 26.54% | 22.33% |
| Free Cash Flow Growth | 44.85% | -6.54% | 3.65% | 134.05% |
| Safety | ||||
| Net Debt / EBITDA | -0.74 | -0.74 | -0.94 | -0.44 |
| Interest Coverage | 284.58 | 473.67 | 340.80 | 1,148.97 |
| Efficiency | ||||
| Inventory Turnover | 2.63 | 1.85 | 2.01 | 1.26 |
| Cash Conversion Cycle | 187.28 | 266.47 | 244.77 | 332.81 |